Sequence information
DRAVP ID DRAVPc037
Name Gontivimab(ALX0171)
Sequence
Molecular Formula Not Available
Condition/Disease Respiratory Syncytial Virus Lower Respiratory Tract Infection
Group Phase â…¡clinical trial
Type Antibody
Description Gontivimab is under investigation in clinical trial NCT03468829 (Efficacy and Safety of ALX-0171 in Adult Hematopoietic Stem Cell Transplant (HSCT) Recipients Who Present With Respiratory Syncytial Virus (RSV) Infection).
Active sequence/Structure
External Links
DrugBank Accession Number DB16179
Pubchem ID 402425649
CHEMBL ID CHEMBL4297692
UNII DY8W536BUY
CAS 1257358-38-5
Reference Not Available
ClinicalTrails Information
| NCT Number | Study Title | Condition/Disease | Status | Phase | Sponsor |
|---|---|---|---|---|---|
| NCT02979431 | Dose Ranging Study of ALX-0171 in Infants Hospitalized for Respiratory Syncytial Virus Lower Respiratory Tract Infection (Respire) | Respiratory Syncytial Virus Lower Respiratory Tract Infection Treatment | Completed | Phase 2 | Ablynx |
| NCT03418571 | Evaluation of ALX-0171 in Japanese Children Hospitalized for Respiratory Syncytial Virus Lower Respiratory Tract Infection | Respiratory Syncytial Virus Lower Respiratory Tract Infection Treatment | Terminated (The Sponsor decided to discontinue ALX-0171 development (due to insufficient evidence of | Phase 2 | Ablynx |
